The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Carfilzomib, lenalidomide, and dexamethasone (KRd) versus elotuzumab and KRd in transplant-eligible patients with newly diagnosed multiple myeloma: Post-induction response and MRD results from an open-label randomized phase 3 study.
 
Stefan Knop
Honoraria - Amgen; BMS GmbH & Co. KG; Celgene/Bristol-Myers Squibb; Molecular Partners; Novartis; Sanofi Aventis GmbH
Consulting or Advisory Role - Amgen; BMS GmbH & Co. KG; Oncopeptides; Sanofi/Aventis
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst)
Travel, Accommodations, Expenses - Amgen
 
Thomas Stuebig
Honoraria - Janssen; Miltenyi Biotec; Sanofi
Research Funding - Miltenyi Biotec
Travel, Accommodations, Expenses - Janssen; Sanofi
 
Miriam Kull
Travel, Accommodations, Expenses - Biotest; Takeda
 
Richard Greil
Honoraria - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Gilead Sciences; Merck; MSD; Novartis; Roche; Sandoz; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Gilead Sciences; Janssen; Merck; MSD; Novartis; Roche; Sanofi; Takeda
Research Funding - Abbvie; Abbvie; Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo Europe GmbH (Inst); Gilead Sciences (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Sandoz (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Gilead Sciences; Janssen-Cilag; MSD; Novartis; Roche
 
Normann Steiner
No Relationships to Disclose
 
Florian Bassermann
Honoraria - Amgen; Bristol-Myers Squibb; Janssen
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen
Travel, Accommodations, Expenses - Janssen
 
Axel Nogai
Honoraria - Alexion Pharmaceuticals; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Biotech; Roche; Sanofi; Takeda
Consulting or Advisory Role - Alexion Pharmaceuticals; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Roche; Sanofi; Takeda
 
Marie von Lilienfeld-Toal
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Chugai Pharma; Gilead Sciences; Janssen-Cilag; Medac; Merck KGaA; Novartis; Takeda
Consulting or Advisory Role - 4D Pharma; Celgene; Gilead Sciences; Janssen; MSD; Oncopeptides; Shionogi
Research Funding - Celgene; Gilead Sciences; Novartis; Oncopeptides
 
Snjezana Janjetovic
No Relationships to Disclose
 
Karolin Trautmann-Grill
Honoraria - Amgen; GlaxoSmithKline; Grifols; Takeda
Consulting or Advisory Role - Amgen; GlaxoSmithKline; Novartis; Sanofi; SOBI; Takeda
Research Funding - Amgen; GlaxoSmithKline; Grifols; Janssen; Takeda
 
Max Bittrich
Stock and Other Ownership Interests - Abbvie
Honoraria - Amgen; Bristol-Myers Squibb; Janssen; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Sanofi
Research Funding - Bristol-Myers Squibb; Sanofi
Travel, Accommodations, Expenses - Janssen
 
Monika Martha Engelhardt
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Sanofi; Takeda
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Sanofi; Takeda
 
Anette Hoferer
No Relationships to Disclose
 
Sebastian Theurich
Honoraria - Bristol-Myers Squibb; Janssen; Kyowa Kirin International; Pfizer; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Kyowa Kirin; Pfizer; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen; Kyowa Kirin; Pfizer; Takeda
 
Mascha Binder
Honoraria - Amgen; Janssen-Cilag; Merck; MSD
Consulting or Advisory Role - Janssen-Cilag; MSD
Research Funding - Janssen-Cilag; Novartis
 
Niklas Zojer
Stock and Other Ownership Interests - Fate Therapeutics; Gilead Sciences; Ionis Pharmaceuticals; Nkarta
Honoraria - Amgen; Bristol-Myers Squibb; Janssen; Sanofi; Takeda
Consulting or Advisory Role - Amgen; BeiGene; Bristol-Myers Squibb; Janssen; Sanofi; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Janssen; Sanofi; Takeda
Expert Testimony - Amgen; BeiGene; Bristol-Myers Squibb; Janssen; Sanofi; Takeda
Travel, Accommodations, Expenses - Amgen; BeiGene; Bristol-Myers Squibb; Janssen; Sanofi; Takeda
 
Heinz A. Duerk
Travel, Accommodations, Expenses - Janssen
 
Monika Brueggemann
Consulting or Advisory Role - Amgen
Speakers' Bureau - Amgen; Becton Dickinson; Janssen; Jazz Pharmaceuticals; Pfizer
Research Funding - Amgen
 
Swantje Held
No Relationships to Disclose
 
Hermann Einsele
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Novartis; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Novartis; Sanofi; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb; Celgene (Inst); GlaxoSmithKline; GlaxoSmithKline; Janssen (Inst); Sanofi
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Sanofi; Takeda